(Q44181170)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

main subject

carbapenem antibiotic

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Robbert Crusio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Sriharsha Rao

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Nisarg Changawala

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Ceres Tiu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Joost van Ginkel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Edward Chapnick

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Yizhak Kupfer

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

8 November 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

Scandinavian Journal of Infectious Diseases

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

1-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24206450%20AND%20SRC:MED&resulttype=core&format=json

Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Clinical and economic consequences of ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Population pharmacokinetics of intravenous polymyxin B in critically ill patients: implications for selection of dosage regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Does the activity of the combination of imipenem and colistin in vitro exceed the problem of resistance in metallo-beta-lactamase-producing Klebsiella pneumoniae isolates?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Prediction of creatinine clearance from serum creatinine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Co-carriage rates of vancomycin-resistant Enterococcus and extended-spectrum beta-lactamase-producing bacteria among a cohort of intensive care unit patients: implications for an active surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

"Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

"Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Continuous versus intermittent infusion of polymyxin B in the treatment of infections caused by multidrug-resistant Gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant gram-negative bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

In vitro activity of NXL104 in combination with beta-lactams against Klebsiella pneumoniae isolates producing KPC carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350

In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365548.2013.844350